Literature DB >> 7627154

Lipiodol uptake and retention by human hepatoma cells.

F I Chou1, K C Fang, C Chung, W Y Lui, C W Chi, R S Liu, W K Chan.   

Abstract

Lipodol has important diagnostic and therapeutic uses in hepatoma. However, the mechanisms of its selective, prolonged retention in hepatoma cells is not well understood. Therefore, using oil-red O, light and electron microscopy and neutron activation analysis we have determined that HepG2 cells are characterized by lipiodol deposition and emulsification on the cell surface, action uptake of lipodol by endocytosis, and prolonged intracellular retention. These findings may have major clinical significance in the development of a new treatment for hepatoma patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627154     DOI: 10.1016/0969-8051(94)00112-w

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  8 in total

1.  Transarterial chemoembolization in the treatment of hepatoblastoma in children.

Authors:  Thomas J Vogl; Albert Scheller; Ursula Jakob; Stefan Zangos; Medhat Ahmed; Mohamed Nabil
Journal:  Eur Radiol       Date:  2005-07-08       Impact factor: 5.315

2.  Student award winner in the Ph.D. category for the 2013 society for biomaterials annual meeting and exposition, april 10-13, 2013, Boston, Massachusetts : biomaterial-mediated cancer-specific DNA delivery to liver cell cultures using synthetic poly(beta-amino ester)s.

Authors:  Stephany Y Tzeng; Luke J Higgins; Martin G Pomper; Jordan J Green
Journal:  J Biomed Mater Res A       Date:  2013-04-05       Impact factor: 4.396

Review 3.  The role of interventional radiology in the management of hepatocellular carcinoma.

Authors:  N Molla; N AlMenieir; E Simoneau; M Aljiffry; D Valenti; P Metrakos; L M Boucher; M Hassanain
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

4.  Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center.

Authors:  Kasper J Andersen; Henning Grønbaek; Gerda Elisabeth Villadsen; Anders Riegels Knudsen; Peter Ott; Hendrik Vildstrup; Dennis Tønner Nielsen; Arindam Bharadwaz
Journal:  Indian J Gastroenterol       Date:  2013-12-04

5.  (188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside.

Authors:  Nicolas Lepareur; Valérie Ardisson; Nicolas Noiret; Etienne Garin
Journal:  Int J Mol Imaging       Date:  2012-02-22

6.  Preoperative Interventional Therapy for Childhood Undifferentiated Embryonal Liver Sarcoma: Two Retrospective Cases from a Single Center.

Authors:  Xiaoxia Zhao; Qixing Xiong; Jinhu Wang; Min-Ju Li; Qi Qin; Shoujiang Huang; Weizhong Gu; Qiang Shu; Jinfa Tou
Journal:  European J Pediatr Surg Rep       Date:  2015-11-19

7.  Biodistribution, pharmacokinetics, and organ-level dosimetry for 188Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans.

Authors:  Pedro L Esquinas; Ajit Shinto; Koramadai K Kamaleshwaran; Jephy Joseph; Anna Celler
Journal:  EJNMMI Phys       Date:  2018-12-07

Review 8.  Therapeutic Strategies in HCC: Radiation Modalities.

Authors:  R Gallicchio; A Nardelli; P Mainenti; A Nappi; D Capacchione; V Simeon; C Sirignano; F Abbruzzi; F Barbato; M Landriscina; G Storto
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.